Abstract
Screening and treating prevalent, often overlooked sexually transmitted infections during pregnancy is highly feasible in resource-limited settings. A decade of research shows improved maternal outcomes and potential for better birth outcomes. Much-needed studies on cost-effectiveness, implementation, and causal mechanisms will refine policies and optimize interventions.